🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if immunotherapy (rituximab) added...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2002-08-28
Trial ID
NCT00594815
Treatments Being Tested
This is a pilot/feasibility study designed to investigate the feasibility o...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2002-09
Trial ID
NCT00187057
The purpose of this study is to evaluate two types of chemotherapy for prim...
Status
Unknown
Location
Groupe hospitalier la Pitié Salpétrière
Start Date
2007-07
Trial ID
NCT00503594
Treatments Being Tested
Patients older than 60 years account for half of cases of Primary Central N...
Status
Unknown
Location
Pitié Salpêtrière Hospital
Start Date
2016-06-13
Trial ID
NCT03582254
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00734773
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2007-08-23
Trial ID
NCT00335140
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2011-09
Trial ID
NCT01399372
Treatments Being Tested